The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 02, 2018
Filed:
Dec. 04, 2017
Applicant:
Ocusoft, Inc., Richmond, TX (US);
Inventors:
Nat Adkins, Jr., Richmond, TX (US);
Cynthia Barratt, Richmond, TX (US);
Assignee:
OCuSOFT, Inc., Richmond, TX (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/68 (2006.01); A61K 8/42 (2006.01); A61K 8/86 (2006.01); A61K 8/60 (2006.01); A61K 8/04 (2006.01); A61K 33/20 (2006.01); A61K 9/00 (2006.01); A61K 8/34 (2006.01); A61K 8/44 (2006.01); A61K 8/55 (2006.01); A61K 8/88 (2006.01); A61K 8/20 (2006.01); A61K 8/49 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61Q 19/00 (2006.01); A61Q 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 8/68 (2013.01); A61K 8/046 (2013.01); A61K 8/20 (2013.01); A61K 8/345 (2013.01); A61K 8/42 (2013.01); A61K 8/442 (2013.01); A61K 8/4973 (2013.01); A61K 8/553 (2013.01); A61K 8/602 (2013.01); A61K 8/86 (2013.01); A61K 8/88 (2013.01); A61K 9/0048 (2013.01); A61K 33/20 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61Q 19/005 (2013.01); A61Q 19/007 (2013.01); A61Q 19/10 (2013.01); A61K 2800/49 (2013.01); A61K 2800/524 (2013.01); A61K 2800/87 (2013.01); A61K 2800/884 (2013.01);
Abstract
An ophthalmic composition comprising: (a) a mixture of antimicrobial agents that substantially eliminates at least seven bacterial strains, wherein the mixture includes polyaminopropyl biguanide, a 1,2-glycol, and a sphingoid lipid; (b) a blended surfactant solution that maintains the first ophthalmic composition at a pH between 5.5 and 7.5, wherein the blended surfactant solution has a foaming ability; (c) a foam stabilizer; and (d) a moisturizer.